Search research articles
Contact Us
Filters
Showing results (601-610 of 653) with videos related to
Page
of 66
Sort By:
Kidney Diseases (Basel, Switzerland)
|
February 10, 2025
Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 Trial
Xin-Ling Liang, Ren-Wei Huang, Jian-Teng Xie, et al.
Molecular Cancer Therapeutics
|
January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
Melanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2010
Allele-specific tumor spectrum in pten knockin mice
Hui Wang, Matt Karikomi, Shan Naidu, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 19, 2016
Effect of ABCB1 rs12720464 and rs1055302 polymorphisms in Chinese patients on the time course of action of rocuronium administered as a single dose
Tian-long Qi, Yin-hui Zhou, Jing-jing Yuan, et al.
Nature Metabolism
|
October 3, 2022
HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma
Qi-Tao Chen, Zhi-Yuan Zhang, Qiao-Ling Huang, et al.
Cancer Research
|
April 15, 2010
A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro
Jing-jing Liu, Hui-ni Zeng, Lian-ru Zhang, et al.
Nature Chemical Biology
|
March 31, 2015
Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation
Li Li, Yuan Liu, Hang-zi Chen, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy
Hui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Cold Spring Harbor Molecular Case Studies
|
August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy
Melanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Future Oncology (London, England)
|
February 4, 2022
A phase III trial of neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis
Sheng Lu, Zhong-Yin Yang, Chao Yan, et al.
Page
of 66
Search research articles
Search
Showing results (601-610 of 653) with videos related to
Sort By:
Page
of 66
Kidney Diseases (Basel, Switzerland)
|
February 10, 2025
Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 Trial
Xin-Ling Liang, Ren-Wei Huang, Jian-Teng Xie, et al.
Molecular Cancer Therapeutics
|
January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
Melanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2010
Allele-specific tumor spectrum in pten knockin mice
Hui Wang, Matt Karikomi, Shan Naidu, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 19, 2016
Effect of ABCB1 rs12720464 and rs1055302 polymorphisms in Chinese patients on the time course of action of rocuronium administered as a single dose
Tian-long Qi, Yin-hui Zhou, Jing-jing Yuan, et al.
Nature Metabolism
|
October 3, 2022
HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma
Qi-Tao Chen, Zhi-Yuan Zhang, Qiao-Ling Huang, et al.
Cancer Research
|
April 15, 2010
A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro
Jing-jing Liu, Hui-ni Zeng, Lian-ru Zhang, et al.
Nature Chemical Biology
|
March 31, 2015
Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation
Li Li, Yuan Liu, Hang-zi Chen, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy
Hui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Cold Spring Harbor Molecular Case Studies
|
August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy
Melanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Future Oncology (London, England)
|
February 4, 2022
A phase III trial of neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis
Sheng Lu, Zhong-Yin Yang, Chao Yan, et al.
Page
of 66